Is HFpEF hiding in your practice? An expert debate on the emerging role of diabetologists

PACE-CME funded by an unrestricted educational grant provided by AstraZeneca |
Friday

Chair: Silvio Inzucchi (USA)

08:00 – 08:05IntroductionSilvio Inzucchi (USA)
08:05 – 08:10Update on new developments of HFpEF and diabetesSilvio Inzucchi (USA)
08:10 – 08:15HFpEF and Diabetes: What are the clinical challenges?Pardeep Jhund (UK)
08:15 – 08:30How does new evidence impact the need for identification and management of patients with HFpEF and diabetes?All faculty

Educational Objectives

The overall objectives of the symposium are to:

  • Describe the findings of trials with SGLT2i in patients with heart failure
  • Identify the clinical challenges in HFpEF and diabetes
  • Discuss the role of diabetologists in the identification of HFpEF and early initiation of SGLT2i in a multidisciplinary approach

Supported by an unrestricted educational grant from